CA26410-1 - 0x000000000000397C

Study Number: CA26410
Group Number: 1
Study Requirement: Healthy Male and Female
Stipend: $7,040.00

Study Criteria:

  • Age: 19 - 55
  • BMI: 18 - 30
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat a genetic disorder in which the adrenal glands produce too much or too little of some hormones.
  • Route of Administration: Oral
  • Blood Draws: 61

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: Three - 7 Night Stays & 1 Phone Call

Screening Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Friday 11/30/2018
Monday 12/3/2018

Doctor Exam Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Friday 11/30/2018
Monday 12/3/2018

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 12/13/2018 11:00:00 AM Friday 12/21/2018 9:00:00 AM 1 Lincoln
Check-In Thursday 1/3/2019 11:00:00 AM Friday 1/11/2019 9:00:00 AM 2 Lincoln
Check-In Thursday 1/17/2019 11:00:00 AM Friday 1/25/2019 9:00:00 AM 3 Lincoln
Phone participant* Wednesday 1/30/2019 11:30:00 AM 3 Lincoln